Marginal ascorbate status (hypovitaminosis C) results in an attenuated response to vitamin C supplementation
It gives Novo Nordisk an opportunity to remain competitive on efficacy while it continues developing next-generation therapies. Other drugs have already shown greater efficacy in prior studies, and the broader GLP-1 space is likely to see much more significant change as new molecules enter the market. Balazs called the higher dosage a major jump, noting that the incidences of stomach- and skin-related side effects at this higher dose are meaningful. CLICK HERE FOR MORE HEALTH STORIES This approval is for obesity management, not diabetes treatment, the expert emphasized
Decreased levels of L-carnitine have been observed during pregnancy, supplementation has been shown to help improve plasma levels
Stincone A, Prigione A, Cramer T, Wamelink MMC, Campbell K, Cheung E, et al
Experimental & Molecular Medicine (2016) 7
Remogliflozin etabonate: first global approval